Download Powerpoint - Circulation Research

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
Procoagulant Soluble Tissue Factor Is Released From
Endothelial Cells in Response to Inflammatory Cytokines
by Björn Szotowski, Silvio Antoniak, Wolfgang Poller, Heinz-Peter Schultheiss, and
Ursula Rauch
Circulation Research
Volume 96(12):1233-1239
June 24, 2005
Copyright © American Heart Association, Inc. All rights reserved.
Figure 1. Induction of asHTF and full-length TF mRNA expression in HUVECs in response to
TNF-α (A and C) and IL-6 (B and D) stimulation. +P<0.0005 vs 0 minutes, *P<0.005 vs 0 minutes,
‡P<0.003 versus 0 minutes, ¥P<0.001 vs 0 minutes, #P<0.01 vs 0 minutes, and $P<0.05 vs 0
minutes.
Björn Szotowski et al. Circ Res. 2005;96:1233-1239
Copyright © American Heart Association, Inc. All rights reserved.
Figure 2. Cytokine-induced asHTF expression in HUVECs. Negative controls (A and B).
Björn Szotowski et al. Circ Res. 2005;96:1233-1239
Copyright © American Heart Association, Inc. All rights reserved.
Figure 3. asHTF and full-length TF protein expression on cytokine stimulation: Western blot
analysis of cell lysates (A) and cell culture supernatant (B) detected with a polyclonal antibody
against the extracellular domain of TF. A, lane 1: TNF-α stimulated for 5 hours; lane 2: TNF-α
stimulated for 18 hours; lane 3: control; lane 4: IL-6 stimulated for 5 hours; lane 5: IL-6
stimulated for 18 hours.
Björn Szotowski et al. Circ Res. 2005;96:1233-1239
Copyright © American Heart Association, Inc. All rights reserved.
Figure 4. Redistribution of cellular TFPI to the supernatant due to cytokine stimulation: Western
blot analysis of cell lysates (A) and the corresponding supernatants (B) of unstimulated and
stimulated HUVECs detected with a polyclonal antibody directed against TFPI. Lane 1:
unstimulated control; lane 2: TNF-α treatment for 5 hours; lane 3: TNF-α treatment for 18 hours;
lane 4: IL-6 treatment for 18 hours; lane 5: IL-6 treatment for 5 hours; lane 6: unstimulated
control.
Björn Szotowski et al. Circ Res. 2005;96:1233-1239
Copyright © American Heart Association, Inc. All rights reserved.
Figure 5. Cytokine-induced TF expression and TFPI reduction/secretion in HUVECs. Fluorescent
images of cellular TF (green), TFPI (red), and the nucleus (blue) in HUVECs before (A through C)
and after 5 hour TNF-α (D through F) or IL-6 (G through I) stimulation.
Björn Szotowski et al. Circ Res. 2005;96:1233-1239
Copyright © American Heart Association, Inc. All rights reserved.
Figure 6. Procoagulant activity of cells (A and B), cell supernatant (C through E), and MPs (F) in
response to stimulation with TNF-α (A, C, D, and F) and IL-6 (B and E). •P<0.00001, *P<0.0002,
†P<0.0003, +P<0.0004, #P<0.001, ±P<0.002, ‡P<0.003, §P<0.01, ¥P<0.03, and ¶P<0.05 TF activity
of unstimulated (solid-filled bar) and cytokine-stimulated (open bar) HUVECs at different points
in time (A for TNF-α, B for IL-6).
Björn Szotowski et al. Circ Res. 2005;96:1233-1239
Copyright © American Heart Association, Inc. All rights reserved.
Figure 7. Detection of MPs present in the extracellular fluid of endothelial cells after stimulation
with TNF-α for 5 hours.
Björn Szotowski et al. Circ Res. 2005;96:1233-1239
Copyright © American Heart Association, Inc. All rights reserved.